Agalawatte Plantations PLC (COSE:AGAL.N0000)
62.80
-0.90 (-1.41%)
At close: Aug 1, 2025
Theseus Pharmaceuticals Balance Sheet
Financials in millions LKR. Fiscal year is January - December.
Millions LKR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 406.42 | 469.51 | 159.58 | 55.68 | 41.87 | 14.98 | Upgrade |
Cash & Short-Term Investments | 406.42 | 469.51 | 159.58 | 55.68 | 41.87 | 14.98 | Upgrade |
Cash Growth | 45.11% | 194.21% | 186.61% | 32.98% | 179.53% | 10.47% | Upgrade |
Accounts Receivable | 223.44 | 29.71 | 53.89 | 113.52 | 63.89 | 75.88 | Upgrade |
Other Receivables | - | 0.67 | 66.9 | 126.71 | 0.77 | 0.77 | Upgrade |
Receivables | 223.44 | 30.38 | 120.79 | 240.23 | 64.66 | 76.65 | Upgrade |
Inventory | 443.07 | 468.11 | 503.69 | 728.58 | 388.55 | 287.75 | Upgrade |
Other Current Assets | 21.43 | 154.67 | 96.51 | 89.69 | 103.08 | 78.55 | Upgrade |
Total Current Assets | 1,094 | 1,123 | 880.56 | 1,114 | 598.16 | 457.93 | Upgrade |
Property, Plant & Equipment | 5,745 | 5,596 | 4,893 | 4,059 | 3,628 | 3,340 | Upgrade |
Long-Term Investments | 513.35 | 537.02 | 497.19 | 424.86 | 294.92 | 223.74 | Upgrade |
Other Long-Term Assets | 911.81 | 912.41 | 813.85 | 657.16 | 680.68 | 724.04 | Upgrade |
Total Assets | 8,265 | 8,168 | 7,085 | 6,255 | 5,202 | 4,745 | Upgrade |
Accounts Payable | 421.92 | 92.55 | 60.36 | 121.66 | 100.71 | 39.72 | Upgrade |
Accrued Expenses | - | 100.16 | 95.07 | 121.49 | 115.76 | 246.28 | Upgrade |
Short-Term Debt | - | - | - | 213.07 | 114.77 | 48.54 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | 300.39 | 612.4 | 11.46 | Upgrade |
Current Portion of Leases | 10.46 | 10.15 | 7.4 | 4.57 | 3.75 | 3.25 | Upgrade |
Other Current Liabilities | - | 262.86 | 223.72 | 266.52 | 1,027 | 2,322 | Upgrade |
Total Current Liabilities | 432.38 | 465.72 | 386.55 | 1,028 | 1,975 | 2,671 | Upgrade |
Long-Term Debt | - | - | - | - | - | 13.54 | Upgrade |
Long-Term Leases | 854.04 | 857.14 | 738.12 | 501.02 | 468.58 | 456.7 | Upgrade |
Long-Term Unearned Revenue | 304.24 | 292.33 | 250.9 | 188.11 | 144.74 | 96.71 | Upgrade |
Long-Term Deferred Tax Liabilities | 1,271 | 1,276 | 980.16 | 391.5 | 257.7 | 337.34 | Upgrade |
Total Liabilities | 3,762 | 3,794 | 3,070 | 2,715 | 3,370 | 4,185 | Upgrade |
Common Stock | 2,258 | 2,258 | 2,258 | 2,258 | 2,258 | 2,258 | Upgrade |
Retained Earnings | 2,245 | 2,117 | 1,756 | 1,282 | -426.47 | -1,698 | Upgrade |
Shareholders' Equity | 4,503 | 4,375 | 4,014 | 3,540 | 1,832 | 560.19 | Upgrade |
Total Liabilities & Equity | 8,265 | 8,168 | 7,085 | 6,255 | 5,202 | 4,745 | Upgrade |
Total Debt | 864.5 | 867.29 | 745.52 | 1,019 | 1,199 | 533.49 | Upgrade |
Net Cash (Debt) | -458.08 | -397.78 | -585.94 | -963.37 | -1,158 | -518.51 | Upgrade |
Net Cash Per Share | -2.93 | -2.55 | -3.75 | -6.17 | -7.41 | -4.58 | Upgrade |
Filing Date Shares Outstanding | 156.25 | 156.25 | 156.25 | 156.25 | 156.25 | 156.25 | Upgrade |
Total Common Shares Outstanding | 156.25 | 156.25 | 156.25 | 156.25 | 156.25 | 156.25 | Upgrade |
Working Capital | 661.98 | 656.95 | 494.01 | 86.49 | -1,377 | -2,213 | Upgrade |
Book Value Per Share | 28.82 | 28.00 | 25.69 | 22.66 | 11.72 | 3.59 | Upgrade |
Tangible Book Value | 4,503 | 4,375 | 4,014 | 3,540 | 1,832 | 560.19 | Upgrade |
Tangible Book Value Per Share | 28.82 | 28.00 | 25.69 | 22.66 | 11.72 | 3.59 | Upgrade |
Land | - | - | - | 727.55 | 725.59 | 708.6 | Upgrade |
Buildings | - | 765.81 | 729.38 | - | - | - | Upgrade |
Machinery | - | 878.89 | 850.78 | 840.94 | 825.52 | 775.49 | Upgrade |
Construction In Progress | - | 3.78 | 9.3 | 2.56 | 7.39 | 28.65 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.